Adtalem Global Education (NYSE:CVSA – Get Free Report) announced its quarterly earnings results on Thursday. The company reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.29, FiscalAI reports. The business had revenue of $511.53 million for the quarter. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%.
Adtalem Global Education Stock Performance
Shares of CVSA stock traded down $1.42 on Friday, hitting $127.34. 528,733 shares of the stock were exchanged, compared to its average volume of 360,238. The firm’s 50 day moving average is $128.06 and its two-hundred day moving average is $122.06. Adtalem Global Education has a one year low of $86.97 and a one year high of $142.13. The firm has a market capitalization of $4.31 billion, a PE ratio of 18.03, a P/E/G ratio of 0.94 and a beta of 0.65. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.45.
Wall Street Analysts Forecast Growth
Several brokerages have commented on CVSA. Wall Street Zen raised Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Sunday, September 27th. Truist Financial cut shares of Adtalem Global Education from a “buy” rating to a “hold” rating and set a $140.00 price objective for the company. in a research report on Thursday, September 3rd. Weiss Ratings raised shares of Adtalem Global Education from a “hold (c)” rating to a “hold (c+)” rating in a research report on Wednesday, October 21st. Finally, BMO Capital Markets decreased their price target on Adtalem Global Education from $148.00 to $145.00 and set an “outperform” rating for the company in a report on Monday, October 5th. Two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $151.67.
Check Out Our Latest Research Report on CVSA
Insider Buying and Selling at Adtalem Global Education
In other news, CAO Manjunath Gangadharan sold 1,802 shares of the company’s stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $137.18, for a total value of $247,198.36. Following the transaction, the chief accounting officer owned 5,083 shares of the company’s stock, valued at approximately $697,285.94. This represents a 26.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Douglas G. Beck sold 4,526 shares of Adtalem Global Education stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $135.81, for a total transaction of $614,676.06. Following the sale, the senior vice president owned 28,544 shares of the company’s stock, valued at approximately $3,876,560.64. The trade was a 13.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 20,365 shares of company stock worth $2,704,088. 2.70% of the stock is owned by insiders.
Institutional Investors Weigh In On Adtalem Global Education
An institutional investor recently raised its position in Adtalem Global Education stock. Kendall Capital Management lifted its stake in shares of Adtalem Global Education Inc. (NYSE:CVSA – Free Report) by 23.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,375 shares of the company’s stock after buying an additional 2,753 shares during the quarter. Kendall Capital Management’s holdings in Adtalem Global Education were worth $1,757,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 98.84% of the company’s stock.
About Adtalem Global Education
Adtalem Global Education, Inc is an education services company that provides healthcare and professional education through institutions serving students in the United States and internationally. The company focuses on preparing students for careers in healthcare, including nursing, medicine, veterinary medicine and other health-related fields.
Its portfolio has included Chamberlain University, Walden University, the American University of the Caribbean School of Medicine, Ross University School of Medicine and Ross University School of Veterinary Medicine.
Recommended Stories
- Five stocks we like better than Adtalem Global Education
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.
